Vitamin e and blood coagulation
Pro Research Analysisby 
Searched over 200M research papers
Vitamin E and Blood Coagulation: Mechanisms and Clinical Implications
Vitamin E Supplementation and Bleeding Risk
High doses of vitamin E can interfere with blood coagulation by inhibiting the synthesis of vitamin K-dependent clotting factors, which may lead to serious bleeding events such as gastrointestinal or intracranial hemorrhage, even at only slightly elevated vitamin E levels . This risk is especially pronounced in individuals who are already at risk for vitamin K deficiency or are taking medications that affect coagulation, such as warfarin or non-steroidal anti-inflammatory drugs 156. In both animal and human studies, vitamin E supplementation has been shown to prolong bleeding time and increase the risk of coagulopathy, particularly when combined with other factors that reduce vitamin K activity 256.
Effects on Coagulation Pathways
Vitamin E, alone or in combination with other antioxidants like alpha-lipoic acid or vitamin C, has been found to prolong activated partial thromboplastin time (APTT), indicating an inhibitory effect on the intrinsic coagulation pathway, while not significantly affecting prothrombin time (PT), which reflects the extrinsic pathway 24. In animal studies, supplementation with vitamin E and vitamin C increased PT, APTT, and other coagulation times, suggesting a general reduction in coagulation activity and a protective effect against hypercoagulable states induced by toxins or surgery 3479.
Vitamin E, Platelet Function, and Thrombosis
Vitamin E appears to reduce platelet aggregation and the thromboplastic activity of erythrocytes, which may contribute to its anticoagulant effects . This hypoactivity of platelets and limited destruction of vascular endothelium may help explain the observed reduction in thrombotic complications in experimental models 37. However, in some cases, this effect can lead to excessive bleeding, especially in the presence of other risk factors for coagulopathy 16.
Clinical Observations in Special Populations
In newborns and premature infants, studies have shown mixed results. Some research found no significant effect of vitamin E supplementation on coagulation factors in premature infants , while other studies suggest that low vitamin E levels in newborns may contribute to a hypercoagulable state, and that supplementation can prolong clotting time . This indicates that the effects of vitamin E on coagulation may vary depending on age, baseline vitamin E status, and other individual factors.
Interactions with Vitamin K and Medications
The anticoagulant effect of vitamin E is most pronounced in the context of vitamin K deficiency or when combined with anticoagulant medications like warfarin. In such cases, vitamin E can further reduce vitamin K-dependent clotting factors, leading to a higher risk of bleeding 156. This interaction underscores the importance of monitoring vitamin E intake in patients at risk for bleeding or those on anticoagulant therapy.
Conclusion
Vitamin E can influence blood coagulation by inhibiting vitamin K-dependent clotting factors and reducing platelet aggregation, which may increase bleeding risk, especially in individuals with vitamin K deficiency or those taking anticoagulant medications 1256. While vitamin E may offer protective effects against thrombosis in certain experimental settings, its use should be carefully monitored in clinical practice to avoid adverse bleeding events. The impact of vitamin E on coagulation varies by individual factors, dosage, and the presence of other risk factors, highlighting the need for personalized assessment when considering supplementation.
Sources and full results
Most relevant research papers on this topic